Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Genuv Logo
Genuv Growth Score
5
CB Rank
1635712
Heat Score
54
Genuv is a drug discovery company that develops treatments for degenerative brain diseases and cancer diseases.
Founded
obfuscation
Private Seoul, Seoul-t'ukpyolsi, South Korea11-50 genuv.com
Biopharma
Biotechnology
Therapeutics
Overview

Genuv
Growth Score
5
Heat Score
54

Growth Score5
-6 pts
in past quarter
Heat Score 54
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Genuv

CB Rank
1635712
Genuv is a drug discovery company that develops treatments for degenerative brain diseases and cancer diseases.
Founded
obfuscation
Private Seoul, Seoul-t'ukpyolsi, South Korea11-50 genuv.com
Biopharma
Biotechnology
Therapeutics

Key People

  • Sungho Han Logo
    Sungho Han: Founder and Chief Executive Officer
    Past Role: DNA link, Business Development Director

Details

Legal Name Genuv Inc.
Operating Status Active
Company Type For Profit
Founders  Sungho Han
Phone Number +82 2 542 0318
Contact Email info@genuv.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ATRIVIEW®
A phenotypic drug screening platform for discovering treatments targeting neurodegenerative diseases by assessing molecule effects on neural stem cells in disease-like environments.
SHINE MOUSE®
A proprietary mouse platform that generates diverse antibodies with high affinity and selectivity for challenging or novel therapeutic targets.

Research & Development

Genuv is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Contacts 1

Employee Profiles

News

News and Press

News•Jan 10, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 11, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 13, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 31, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

294
276.92%
 in past month

IT Spend

$82.3KThis year, Genuv is projected to spend $82.3K on IT, according to Aberdeen.

Active Website Tech Count

28Genuv is actively using 28 technologies for its website, according to BuiltWith. These include SPF, Google Font API, and  Apple Mobile Web Clips Icon.

Total IP

18The intellectual property of Genuv includes 11 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Genuv has registered 7 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Genuv's headquarters? Genuv is located in Seoul, Seoul-t'ukpyolsi, South Korea.Who are Genuv's competitors? Alternatives and possible competitors to Genuv may include Genmab, AbCellera, and  Denali Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8ea058e 1)
|